Benzonatate Suppliers & Bulk Manufacturers
Available Forms: Capsules
Available Strengths: 100 mg, 150 mg, 200 mg
Reference Brands: Tessalon (USA),
Category:
Respiratory Disorder
Benzonatate is available in Capsules
and strengths such as 100 mg, 150 mg, 200 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Benzonatate is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Benzonatate can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Benzonatate is a prescription non-opioid medication used for the symptomatic relief of cough, marketed under the brand name Tessalon and other regional brands. It is taken orally and provides rapid relief, with effects typically beginning within 20 minutes and lasting between 3 and 8 hours. Benzonatate works by numbing the stretch receptors in the lungs and airways, which suppresses the cough reflex and reduces the urge to cough.
This medication is effective for managing cough associated with a wide range of respiratory conditions, including asthma, bronchitis, pneumonia, tuberculosis, pneumothorax, emphysema, and opioid-resistant cough in lung cancer patients. Additionally, benzonatate helps decrease the consistency and volume of sputum production in individuals with chronic obstructive pulmonary disease (COPD), improving overall respiratory comfort.
Benzonatate offers a non-narcotic alternative to traditional opioid cough suppressants, making it a safer option for long-term use or for patients where opioid medications are contraindicated. Administered under medical supervision, benzonatate provides targeted cough relief while minimizing potential side effects, making it a widely prescribed and reliable therapy for adults and children with persistent coughs caused by various respiratory illnesses.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing